EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY-NC-ND 4.0

The influence of voxelotor on cerebral blood flow and oxygen extraction in pediatric sickle cell disease

Rowan O Brothers iD, Katherine B Turrentine, Mariam Akbar, Sydney Triplett, Hongting Zhao iD, Tara M Urner iD, Adam Goldman-Yassen iD, Richard A Jones iD, Jack Knight-Scott, Sarah S Milla, Shasha Bai iD, Amy Tang und 2 weitere

Blood · 2024

DOI: 10.1182/blood.2023022011 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Blood, 2024. Verfasst von Rowan O Brothers und 13 weiteren Autor:innen. Beteiligte Einrichtung: Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Cerebrovascular Circulation, Oxygen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Voxelotor is an inhibitor of sickle hemoglobin polymerization that is used to treat sickle cell disease. Although voxelotor has been shown to improve anemia, the clinical benefit on the brain remains to be determined. This study quantified the cerebral hemodynamic effects of voxelotor in children with sickle cell anemia (SCA) using noninvasive diffuse optical spectroscopies. Specifically, frequency-domain near-infrared spectroscopy combined with diffuse correlation spectroscopy were used to noninvasively assess regional oxygen extraction fraction (OEF), cerebral blood volume, and an index of cerebral blood flow (CBFi). Estimates of CBFi were first validated against arterial spin–labeled magnetic resonance imaging (ASL-MRI) in 8 children with SCA aged 8 to 18 years. CBFi was significantly positively correlated with ASL-MRI–measured blood flow (R2 = 0.651; P = .015). Next, a single-center, open-label pilot study was completed in 8 children with SCA aged 4 to 17 years on voxelotor, monitored before treatment initiation and at 4, 8, and 12 weeks (NCT05018728). By 4 weeks, both OEF and CBFi significantly decreased, and these decreases persisted to 12 weeks (both P < .05). Decreases in CBFi were significantly correlated with increases in blood hemoglobin (Hb) concentration (P = .025), whereas the correlation between decreases in OEF and increases in Hb trended toward significance (P = .12). Given that previous work has shown that oxygen extraction and blood flow are elevated in pediatric SCA compared with controls, these results suggest that voxelotor may reduce cerebral hemodynamic impairments. This trial was registered at www.ClinicalTrials.gov as #NCT05018728.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellCerebrovascular CirculationOxygenHumansChildAdolescentMaleFemaleChild, PreschoolMagnetic Resonance ImagingPyrazinesPilot ProjectsBenzaldehydesSpectroscopy, Near-InfraredPyrazoles

Substanzen

voxelotorOxygenPyrazinesBenzaldehydesPyrazoles

Autor:innen und Institutionen

  • Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA.
  • Department of Radiology and Imaging Sciences, Children's Healthcare of Atlanta and Emory University, Atlanta, GA.
  • Department of Radiology, Children's Healthcare of Atlanta, Atlanta, GA.
  • Department of Pediatric Radiology, Children's Hospital Colorado, Aurora, CO.
  • Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO.
  • Pediatric Biostatistics Core, Emory University School of Medicine, Atlanta, GA.

ORCID-Profile: Rowan O Brothers, Hongting Zhao, Tara M Urner, Adam Goldman-Yassen, Richard A Jones, Shasha Bai

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Brothers, R. O., Turrentine, K. B., Akbar, M., Triplett, S., Zhao, H., Urner, T. M., Goldman-Yassen, A., Jones, R. A., Knight-Scott, J., Milla, S. S., Bai, S., Tang, A., Brown, R. C., & Buckley, E. M. (2024). The influence of voxelotor on cerebral blood flow and oxygen extraction in pediatric sickle cell disease. Blood. https://doi.org/10.1182/blood.2023022011

Vancouver

Brothers RO, Turrentine KB, Akbar M, Triplett S, Zhao H, Urner TM, et al. The influence of voxelotor on cerebral blood flow and oxygen extraction in pediatric sickle cell disease. Blood. 2024. doi:10.1182/blood.2023022011

BibTeX
@article{Brothers2024,
  author = {Brothers, Rowan O and Turrentine, Katherine B and Akbar, Mariam and Triplett, Sydney and Zhao, Hongting and Urner, Tara M and Goldman-Yassen, Adam and Jones, Richard A and Knight-Scott, Jack and Milla, Sarah S and Bai, Shasha and Tang, Amy and Brown, R Clark and Buckley, Erin M},
  title = {The influence of voxelotor on cerebral blood flow and oxygen extraction in pediatric sickle cell disease},
  journal = {Blood},
  year = {2024},
  doi = {10.1182/blood.2023022011}
}
Kostenlos starten →